Thanks, David. I'm going to start on Slide 4. As David just previewed, adjusted NII per share was $0.48, corresponding to an adjusted NII ROE of 12.7%. Compared to fiscal Q3 of 2023, GBDC's adjusted NII per share increased by $0.04 year-over-year or about 9%. Adjusted earnings per share was $0.31, corresponding to an adjusted net income ROE of 8.1%. Taking a step back, GBDC's earnings were driven by multiple key factors. First, credit performance was solid generally with the exceptions of markdowns on Imperial Optical and Pluralsight that drove the majority of the $0.17 per share net realized and unrealized loss. I'll go into more detail in a moment. Second, we continue to experience high base rates consistent with recent quarters. Third, GBDC's leading investment advisory fee structure drives sustainably lower expenses. This includes the reduction in the incentive fee rate from 20% to 15%, which became permanent with the closing of the GBDC 3 merger on June 3, 2024. And finally, Golub Capital, GBDCs Investment manager elected to voluntarily waive the manager's incentive fee this quarter. This equated to approximately $0.07 per share benefit to net investment income and earnings. This fee waiver continues the long tradition of Golub Capital taking shareholder friendly actions. Let me summarize portfolio activity and credit quality in the quarter. Net funds increased by $2.5 billion sequentially, primarily the result of the closing of the GBDC 3 merger, bringing the size of the total portfolio at fair value to $7.9 billion. The overall credit performance of GBDC's investment portfolio remains strong with internal performance ratings improving from the prior quarter. Investments in rating categories four and five increased to 89.2% from 87.2% in the prior quarter and investments in rating categories one and two represented just 70 basis points of the total portfolio at fair value. As a percentage of total debt investments at fair value, non-accruals increased slightly to 1% at June 30, 2024 from 90 basis points at March 31, 2024 and continue to be well below the BDC sector average. In the quarter the number of non-accrual investments increased to 10 as the return to accrual status of one portfolio company was offset by the addition of two portfolio companies. We continue to believe the overall portfolio is well positioned from a credit perspective. The weighted average loan-to-value of the portfolio was 45%, which we believe provides very nice downside protection. Despite these generally positive credit trends, we did have the two negative surprises in the quarter that David highlighted in his opening remarks. We don't think they are representative of the broader health of the portfolio and it's probably worth a moment to really discuss Imperial Optical in more detail given its relative size and impact on this quarter's results. Imperial Optical is a full-service vision care platform that offers optometric patient care and retail eyewear products through 280 locations across the U.S. Our exposure to Imperial Optical at March 31, 2024 consisted of $96.9 million face amount of senior secured debt at pre-merger GBDC and $41.7 million face amount at pre-merger GBDC 3. The company's been underperforming our and the sponsor's expectations for some time. With the support of the sponsor, last year we undertook a two-pronged strategy. First, the company implemented an operating turnaround plan, including a new CEO. Second, it explored strategic alternatives. As of 03/31/2024, we believe there was a high probability of a strategic exit. However, over the course of the quarter ended 6/30, it became clear this was not going to happen. Accordingly, we shifted to a singular focus on the operating turnaround. We rightsized its capital structure and took control of the equity and Board. We worked closely with existing management and other key stakeholders to ensure alignment. This restructuring drove the majority of GBDC's net realized and unrealized loss in the quarter. Continuing on Slide 4, let me briefly summarize certain balance sheet changes in the quarter. NAV per share increased by $0.20 on a sequential basis to $15.32. NAV per share is now $0.49 higher than the prior year, even as GBDC delivered higher distributions to shareholders during this period. As David described earlier, one of the benefits of the recently closed merger with GBDC 3 is that shares issued in the merger, approximately $92 million, were issued at a price in excess of the current NAV, resulting in material NAV accretion for existing GBDC shareholders. Leverage decreased materially quarter-over-quarter to 1.05x on a debt-to-equity basis net of available cash. And to 1.00x net of available cash and cash trapped at debt securitizations for the purposes of paying down principal on outstanding notes. We described last quarter that we expected a level of deleveraging in connection with the merger, and we got it. Let's turn to distributions now. The Board approved $0.44 per share of distributions comprised of a regular quarterly distribution of $0.39 share and a fiscal Q3 supplemental distribution of $0.05 per share. Taken together, these distributions correspond to an annualized dividend yield of 11.5% based on GBDC's NAV per share as of June 30, 2024. Adjusted NII per share continues to significantly exceed the company's regular quarterly distribution, resulting in regular distribution coverage of 123%. In addition, our Board declared additional special distributions to be paid in three equal installments of $0.05 per share, which began in June 2024 following the merger close on June 3. The remaining two special distributions of $0.05 per share will be paid on September 13, 2024 for stockholders of record as of August 16, 2024 and December 13, 2024 for stockholders of record as of November 29, 2024. You can find more information about the record dates and payment dates for fiscal Q3 distributions on Slide 25 of the earnings presentation and about the variable supplemental distribution framework on Slide 26. Lastly, and before I turn it over to Chris to walk through the financial results in more detail, we've outlined on Slide 6, which is a new slide, the key nonrecurring items that impacted the P&L in the June 30 quarter. The intent of this analysis is to better show what we believe is a more normalized GBDC core earnings profile before the impacts of modestly re-leveraging the balance sheet. First, the reversal of interest income recognized in prior quarters on investments restructured or placed on non-accrual status this quarter reduced adjusted NII per share by $0.01. Second, in the quarter, GBDC recognized an additional $0.03 per share of non-cash interest expense associated with marking to market interest rate swaps. Again, these are noncash charges that should sum to zero over time. And lastly, the incentive fee waiver contributed to a $0.07 per share increase in adjusted NII. The net results of these adjustments for non-recurring items is an adjusted NII per share of $0.45 or an 11.7% adjusted NII ROE. Further, as I mentioned earlier, we expect that re-leveraging GBDC's balance sheet to target levels in response to the deleveraging impact of the GBDC 3 merger would be an NII tailwind. I'm going to turn it to Chris now to provide more detail on our results.